Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Frits Van Rhee

Concepts (589)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
167
2026
3082
11.320
Why?
Antibodies, Monoclonal
26
2024
477
5.760
Why?
Hematopoietic Stem Cell Transplantation
29
2026
610
3.120
Why?
Antineoplastic Agents
18
2024
1232
3.010
Why?
Antineoplastic Combined Chemotherapy Protocols
42
2024
1043
3.000
Why?
Humans
223
2026
53246
2.190
Why?
Monoclonal Gammopathy of Undetermined Significance
11
2025
123
1.910
Why?
Thalidomide
24
2024
378
1.850
Why?
Neoplasm Recurrence, Local
15
2024
647
1.660
Why?
Transplantation, Autologous
27
2026
488
1.640
Why?
Immunotherapy, Adoptive
9
2024
163
1.600
Why?
Killer Cells, Natural
8
2024
113
1.580
Why?
Middle Aged
83
2026
13422
1.560
Why?
Gene Expression Profiling
28
2025
1112
1.540
Why?
Interleukin-6
12
2023
272
1.510
Why?
Neoplasm Proteins
13
2022
330
1.450
Why?
Hematologic Neoplasms
3
2022
101
1.450
Why?
Aged
83
2026
10430
1.420
Why?
Prognosis
48
2025
2118
1.410
Why?
Antigens, Neoplasm
6
2014
146
1.310
Why?
Clinical Trials as Topic
13
2022
466
1.300
Why?
Antibodies, Bispecific
7
2025
108
1.270
Why?
Stem Cell Transplantation
10
2022
191
1.230
Why?
Adult
63
2026
14541
1.230
Why?
B-Cell Maturation Antigen
9
2025
101
1.210
Why?
Male
93
2026
27444
1.170
Why?
Gene Expression Regulation, Neoplastic
20
2022
868
1.160
Why?
Female
95
2026
28792
1.150
Why?
Combined Modality Therapy
19
2024
640
1.140
Why?
Chromosomes, Human, Pair 1
9
2023
95
1.120
Why?
Herpesvirus 8, Human
7
2021
98
1.100
Why?
Translocation, Genetic
10
2022
266
1.070
Why?
Treatment Outcome
47
2024
5597
1.020
Why?
Boronic Acids
12
2013
180
1.010
Why?
Pyrazines
12
2013
188
1.000
Why?
Bone Marrow
18
2024
359
0.960
Why?
Plasma Cells
12
2025
234
0.950
Why?
Proteasome Inhibitors
5
2024
104
0.940
Why?
Immunotherapy
6
2024
266
0.890
Why?
Neoplasms, Second Primary
2
2024
75
0.890
Why?
Disease-Free Survival
24
2019
466
0.850
Why?
Dexamethasone
14
2024
429
0.830
Why?
B-Lymphocytes
5
2024
178
0.830
Why?
T-Lymphocytes, Cytotoxic
4
2014
67
0.800
Why?
Melphalan
9
2020
180
0.790
Why?
Cancer Vaccines
3
2010
79
0.780
Why?
Follow-Up Studies
26
2024
2318
0.780
Why?
Hyperhidrosis
1
2022
2
0.750
Why?
Sweat
1
2022
9
0.740
Why?
Survival Rate
24
2020
949
0.730
Why?
Lymphoma, B-Cell
3
2022
60
0.720
Why?
Drug Approval
1
2022
41
0.710
Why?
Aged, 80 and over
24
2026
3495
0.700
Why?
Positron-Emission Tomography
8
2025
299
0.690
Why?
T-Lymphocytes
8
2024
320
0.680
Why?
Patient Participation
1
2022
72
0.680
Why?
Ehrlichia chaffeensis
1
2021
5
0.680
Why?
Cryosurgery
1
2021
36
0.670
Why?
Ehrlichiosis
1
2021
15
0.670
Why?
Disease Progression
17
2025
880
0.650
Why?
Immunoglobulin Light Chains
3
2017
90
0.650
Why?
Lymphohistiocytosis, Hemophagocytic
1
2021
31
0.650
Why?
Embolization, Therapeutic
1
2021
91
0.630
Why?
Cell Proliferation
10
2023
1031
0.620
Why?
Neoplasm, Residual
9
2025
171
0.610
Why?
Chromosomal Instability
1
2019
16
0.600
Why?
Neoplasms, Plasma Cell
3
2024
35
0.590
Why?
Membrane Proteins
3
2006
333
0.590
Why?
Survival Analysis
18
2024
659
0.580
Why?
Adrenal Cortex Hormones
2
2023
116
0.570
Why?
Immunologic Factors
2
2018
117
0.570
Why?
Chromosome Aberrations
12
2023
297
0.550
Why?
Epigenesis, Genetic
4
2023
412
0.550
Why?
Dendritic Cells
3
2014
133
0.540
Why?
Tumor Microenvironment
6
2024
274
0.540
Why?
POEMS Syndrome
1
2018
34
0.540
Why?
Atrial Fibrillation
2
2022
196
0.530
Why?
Thyroid Neoplasms
1
2019
113
0.530
Why?
Polymorphism, Single Nucleotide
3
2024
505
0.520
Why?
Prealbumin
2
2014
22
0.510
Why?
Antibodies, Monoclonal, Humanized
6
2023
238
0.500
Why?
Receptors, Interleukin-6
2
2014
22
0.490
Why?
Cardiomyopathies
2
2014
120
0.460
Why?
Mutation
10
2022
1338
0.460
Why?
Risk Assessment
11
2025
1368
0.440
Why?
Risk Factors
21
2026
4018
0.440
Why?
Osteolysis
4
2022
74
0.430
Why?
Immunotoxins
1
2014
6
0.420
Why?
Recurrence
13
2024
694
0.410
Why?
Cytotoxicity, Immunologic
2
2012
55
0.410
Why?
Drug Resistance, Neoplasm
7
2024
350
0.410
Why?
Clonal Evolution
3
2020
59
0.400
Why?
Practice Guidelines as Topic
4
2023
502
0.400
Why?
Hematopoietic Stem Cells
3
2026
189
0.390
Why?
Health Status
1
2015
306
0.390
Why?
Cyclophosphamide
5
2021
178
0.390
Why?
Amyloidosis
1
2014
83
0.380
Why?
Transplantation, Homologous
5
2017
154
0.380
Why?
Thrombocytopenia
3
2025
89
0.380
Why?
Diffusion Magnetic Resonance Imaging
3
2025
133
0.370
Why?
Fluorodeoxyglucose F18
6
2021
182
0.370
Why?
Neutropenia
2
2023
113
0.360
Why?
Remission Induction
13
2021
222
0.360
Why?
Genome-Wide Association Study
3
2024
184
0.360
Why?
Receptors, KIR
2
2008
11
0.350
Why?
Genetic Predisposition to Disease
3
2024
533
0.340
Why?
Bone Diseases
3
2021
94
0.340
Why?
Dose-Response Relationship, Drug
8
2020
1367
0.340
Why?
Prospective Studies
9
2025
2412
0.340
Why?
Cytokines
3
2025
627
0.340
Why?
Pyrimidines
2
2022
206
0.340
Why?
Lymph Nodes
5
2025
252
0.330
Why?
Azacitidine
1
2010
39
0.330
Why?
Benzamides
1
2010
52
0.320
Why?
Evolution, Molecular
2
2021
97
0.320
Why?
Histone Deacetylase Inhibitors
1
2010
60
0.320
Why?
C-Reactive Protein
6
2022
152
0.310
Why?
Prednisone
2
2021
101
0.310
Why?
Doxorubicin
6
2021
248
0.310
Why?
Drug Administration Schedule
5
2015
370
0.300
Why?
TOR Serine-Threonine Kinases
2
2020
83
0.300
Why?
Chromosome Deletion
5
2023
138
0.300
Why?
In Situ Hybridization, Fluorescence
6
2026
266
0.290
Why?
Pelvis
2
2021
66
0.290
Why?
Metaphase
4
2016
47
0.290
Why?
Quality of Life
1
2015
902
0.290
Why?
Vaccination
4
2022
310
0.290
Why?
Membrane Glycoproteins
2
2009
238
0.290
Why?
Animals
15
2024
13528
0.280
Why?
Paraproteinemias
3
2022
72
0.280
Why?
Disease Management
3
2025
187
0.280
Why?
Proportional Hazards Models
7
2024
445
0.280
Why?
Placebo Effect
2
2020
16
0.270
Why?
Bone Neoplasms
4
2013
188
0.270
Why?
Fever
3
2025
112
0.270
Why?
Young Adult
8
2025
4514
0.270
Why?
Adoptive Transfer
1
2007
29
0.270
Why?
Retrospective Studies
14
2026
6821
0.260
Why?
Histocompatibility Antigens Class I
1
2007
47
0.260
Why?
Chromatin
3
2023
145
0.260
Why?
CD8-Positive T-Lymphocytes
3
2024
145
0.260
Why?
Cytogenetic Analysis
5
2023
79
0.260
Why?
DNA Methylation
4
2023
592
0.250
Why?
Boron Compounds
2
2024
20
0.250
Why?
Registries
4
2025
652
0.250
Why?
Chromans
2
2024
34
0.250
Why?
Vincristine
3
2021
89
0.250
Why?
Cell Membrane
1
2007
233
0.250
Why?
Mice, SCID
6
2013
180
0.240
Why?
Angiogenesis Inhibitors
5
2010
186
0.240
Why?
Glycine
2
2024
75
0.240
Why?
Down-Regulation
1
2007
344
0.240
Why?
Neoplasm Staging
6
2024
774
0.230
Why?
Antigens, CD34
1
2026
76
0.230
Why?
Cytomegalovirus
1
2026
42
0.230
Why?
Cell Line, Tumor
9
2023
1470
0.230
Why?
Consensus
3
2025
206
0.230
Why?
Vitamin E
2
2024
76
0.230
Why?
Chromosomes, Human, Pair 17
2
2017
35
0.230
Why?
Cytomegalovirus Infections
1
2026
49
0.230
Why?
Virus Activation
1
2026
49
0.230
Why?
Mice
11
2024
5982
0.230
Why?
Case-Control Studies
6
2024
1212
0.230
Why?
Transplantation Conditioning
5
2008
96
0.230
Why?
Bone Resorption
2
2022
304
0.220
Why?
Infusions, Intravenous
3
2015
211
0.220
Why?
Flow Cytometry
4
2012
400
0.220
Why?
Connective Tissue Diseases
1
2025
20
0.220
Why?
Antibody Formation
1
2005
49
0.220
Why?
Immunoglobulins, Intravenous
1
2025
64
0.210
Why?
Time Factors
11
2021
2992
0.210
Why?
Polycomb Repressive Complex 2
2
2021
48
0.210
Why?
Diagnosis, Differential
2
2026
1038
0.210
Why?
Autoantibodies
1
2025
120
0.210
Why?
Monocytes
2
2020
126
0.200
Why?
Gene Expression
2
2018
618
0.200
Why?
High-Throughput Nucleotide Sequencing
3
2022
181
0.200
Why?
Cell Cycle Proteins
2
2022
170
0.200
Why?
Blotting, Western
3
2015
587
0.200
Why?
Epstein-Barr Virus Infections
2
2020
32
0.190
Why?
Signal Transduction
6
2021
1748
0.190
Why?
Radiation-Protective Agents
1
2024
69
0.190
Why?
Proteasome Endopeptidase Complex
3
2011
142
0.190
Why?
Integrin beta Chains
1
2023
14
0.190
Why?
Hematopoietic Stem Cell Mobilization
3
2026
63
0.190
Why?
Ubiquitin-Protein Ligases
1
2024
140
0.190
Why?
Integrins
1
2023
34
0.190
Why?
Cross-Sectional Studies
3
2023
1723
0.190
Why?
Double-Blind Method
2
2015
729
0.190
Why?
Sweating
1
2022
13
0.190
Why?
Proto-Oncogene Proteins B-raf
2
2020
78
0.180
Why?
Tumor Cells, Cultured
4
2013
441
0.180
Why?
Proteomics
3
2021
337
0.180
Why?
Kaplan-Meier Estimate
10
2016
487
0.180
Why?
DNA, Intergenic
1
2022
6
0.180
Why?
Immunoconjugates
1
2022
37
0.180
Why?
Tumor Suppressor Protein p53
2
2017
228
0.180
Why?
Receptors, Antigen, T-Cell
1
2022
52
0.180
Why?
Waldenstrom Macroglobulinemia
1
2022
38
0.180
Why?
United States Food and Drug Administration
1
2022
93
0.170
Why?
United States
4
2022
5413
0.170
Why?
Influenza, Human
1
2022
88
0.170
Why?
Apoptosis
5
2018
1139
0.170
Why?
Chromosomes, Human, Pair 14
3
2020
76
0.170
Why?
Mediastinum
1
2021
22
0.170
Why?
Receptors, Glucocorticoid
2
2012
34
0.170
Why?
Epigenomics
1
2021
76
0.170
Why?
Phosphatidylinositol 3-Kinases
2
2019
148
0.170
Why?
Axilla
1
2021
92
0.170
Why?
Ubiquitination
1
2021
58
0.170
Why?
Alleles
3
2021
277
0.170
Why?
Multiple Organ Failure
1
2021
51
0.170
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
92
0.170
Why?
Lymphoma, Large B-Cell, Diffuse
1
2022
110
0.160
Why?
Salvage Therapy
6
2013
138
0.160
Why?
Proto-Oncogene Proteins c-maf
2
2020
19
0.160
Why?
Adolescent
7
2025
6912
0.160
Why?
Epstein-Barr Virus Nuclear Antigens
1
2020
1
0.160
Why?
Interferon-gamma
3
2014
174
0.160
Why?
Rare Diseases
1
2020
47
0.160
Why?
Transcriptome
5
2025
368
0.160
Why?
Genes, Tumor Suppressor
2
2021
73
0.160
Why?
Radiopharmaceuticals
4
2021
198
0.160
Why?
Cell Cycle
1
2021
237
0.160
Why?
Longitudinal Studies
5
2024
774
0.160
Why?
Interferon Type I
1
2020
28
0.160
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.160
Why?
Myelodysplastic Syndromes
2
2013
87
0.150
Why?
Multivariate Analysis
8
2021
598
0.150
Why?
ROC Curve
2
2025
246
0.150
Why?
Leukemia, Plasma Cell
1
2020
35
0.150
Why?
Research Design
2
2020
373
0.150
Why?
Genomics
4
2023
271
0.150
Why?
DNA
1
2023
535
0.150
Why?
Gene Amplification
1
2019
58
0.150
Why?
Immunohistochemistry
2
2015
975
0.150
Why?
Measles virus
1
2019
8
0.150
Why?
Measles
1
2019
7
0.150
Why?
Gene Regulatory Networks
1
2020
112
0.150
Why?
Hematopoiesis, Extramedullary
1
2019
9
0.150
Why?
Data Collection
1
2020
288
0.150
Why?
Health Status Disparities
1
2022
221
0.150
Why?
Biopsy
5
2018
600
0.150
Why?
Oncolytic Virotherapy
1
2019
28
0.150
Why?
Patient Safety
1
2020
103
0.150
Why?
Sirolimus
1
2019
72
0.140
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
9
0.140
Why?
Cell Differentiation
6
2022
681
0.140
Why?
Precancerous Conditions
2
2010
87
0.140
Why?
Evidence-Based Medicine
2
2018
275
0.140
Why?
Syndrome
1
2019
248
0.140
Why?
Healthcare Disparities
1
2022
312
0.140
Why?
Proto-Oncogene Proteins c-akt
1
2019
171
0.140
Why?
Spleen
1
2019
166
0.140
Why?
MafB Transcription Factor
1
2018
9
0.140
Why?
Graft vs Host Disease
4
2007
93
0.140
Why?
Genomic Instability
2
2016
88
0.140
Why?
Immunomodulation
1
2018
36
0.140
Why?
Phosphotransferases
1
2018
18
0.140
Why?
Chemokines
1
2018
78
0.130
Why?
Osteoclasts
3
2022
428
0.130
Why?
Plasma
1
2018
47
0.130
Why?
Myeloablative Agonists
2
2008
32
0.130
Why?
Magnetic Resonance Imaging
5
2013
1587
0.130
Why?
Models, Biological
2
2018
737
0.130
Why?
Adipocytes
1
2018
131
0.130
Why?
Genes, Neoplasm
2
2015
31
0.130
Why?
Gene Dosage
2
2015
76
0.130
Why?
Gene Rearrangement
1
2018
76
0.130
Why?
Communication
1
2019
263
0.130
Why?
Hexokinase
1
2017
16
0.130
Why?
Heterozygote
2
2014
89
0.130
Why?
Protein-Tyrosine Kinases
2
2018
87
0.130
Why?
Calcification, Physiologic
1
2017
42
0.130
Why?
HLA-A Antigens
2
2007
11
0.120
Why?
Drug Therapy, Combination
1
2018
405
0.120
Why?
Oligonucleotide Array Sequence Analysis
5
2010
412
0.120
Why?
Gene Frequency
2
2013
97
0.120
Why?
Syndecan-1
4
2021
73
0.120
Why?
Gene Expression Regulation, Enzymologic
1
2017
180
0.120
Why?
Critical Illness
1
2018
316
0.120
Why?
Lymphocyte Activation
2
2017
163
0.120
Why?
Tumor Burden
3
2020
132
0.120
Why?
Confidence Intervals
2
2014
158
0.110
Why?
Immunity, Innate
1
2016
112
0.110
Why?
Erythrocyte Indices
1
2015
7
0.110
Why?
Biomarkers, Pharmacological
2
2012
26
0.110
Why?
DNA Copy Number Variations
3
2022
117
0.110
Why?
Coculture Techniques
2
2013
146
0.110
Why?
Hemoglobins
2
2013
114
0.110
Why?
Cysteine-Rich Protein 61
1
2014
3
0.110
Why?
Hematologic Diseases
1
2014
21
0.110
Why?
Half-Life
1
2014
86
0.100
Why?
International Cooperation
1
2014
52
0.100
Why?
Enzyme-Linked Immunosorbent Assay
1
2015
233
0.100
Why?
Fatigue
1
2015
127
0.100
Why?
Iron
1
2015
130
0.100
Why?
Area Under Curve
1
2014
185
0.100
Why?
Antibodies
2
2024
147
0.100
Why?
Amyloid Neuropathies, Familial
1
2013
5
0.100
Why?
Reference Values
1
2014
311
0.100
Why?
Renal Insufficiency
2
2021
108
0.100
Why?
Disease Models, Animal
2
2016
1517
0.100
Why?
Emotions
1
2015
177
0.100
Why?
Antineoplastic Agents, Alkylating
3
2008
78
0.100
Why?
Severity of Illness Index
2
2014
1049
0.100
Why?
Neoplasms, Glandular and Epithelial
1
2014
42
0.100
Why?
Cisplatin
4
2013
282
0.100
Why?
Inflammation Mediators
1
2014
115
0.100
Why?
Administration, Metronomic
1
2013
7
0.100
Why?
Cystatin M
2
2024
17
0.100
Why?
Macaca mulatta
2
2024
94
0.100
Why?
Nicotinamide Phosphoribosyltransferase
1
2013
6
0.100
Why?
Central Nervous System Neoplasms
1
2013
69
0.090
Why?
beta Catenin
1
2013
107
0.090
Why?
Oligopeptides
1
2013
94
0.090
Why?
Venous Thrombosis
2
2004
91
0.090
Why?
Antibody-Dependent Cell Cytotoxicity
2
2009
12
0.090
Why?
Edema
2
2025
64
0.090
Why?
Leukemia
1
2013
67
0.090
Why?
Cell Survival
2
2020
600
0.090
Why?
Myelolipoma
1
2012
9
0.090
Why?
Pain
1
2015
353
0.090
Why?
Mental Health
1
2015
249
0.090
Why?
Interleukin Receptor Common gamma Subunit
1
2012
7
0.090
Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2012
8
0.090
Why?
Clone Cells
2
2023
76
0.090
Why?
Maintenance Chemotherapy
1
2012
52
0.090
Why?
Vascular Endothelial Growth Factor A
1
2013
189
0.090
Why?
Models, Genetic
2
2016
169
0.090
Why?
Adaptor Proteins, Signal Transducing
2
2024
202
0.090
Why?
Interleukin-2
1
2012
69
0.090
Why?
Mice, Inbred NOD
1
2012
90
0.090
Why?
Immunoenzyme Techniques
1
2012
134
0.090
Why?
Cell Movement
1
2013
279
0.090
Why?
Hemangioma
1
2013
86
0.090
Why?
Soft Tissue Neoplasms
1
2012
62
0.090
Why?
Karyotype
2
2026
22
0.090
Why?
Immunoglobulin G
2
2025
192
0.090
Why?
Arkansas
5
2021
2068
0.090
Why?
Genotype
1
2013
563
0.090
Why?
Transcriptional Elongation Factors
2
2022
17
0.080
Why?
Transduction, Genetic
2
2014
44
0.080
Why?
Models, Statistical
2
2014
229
0.080
Why?
Chemokine CXCL13
2
2022
6
0.080
Why?
Peripheral Blood Stem Cell Transplantation
2
2008
59
0.080
Why?
Mutation Rate
2
2021
36
0.080
Why?
Immunoglobulin Idiotypes
1
2010
5
0.080
Why?
CD40 Ligand
1
2010
14
0.080
Why?
Hypersensitivity, Delayed
1
2010
18
0.080
Why?
Interleukin-4
1
2010
40
0.080
Why?
Up-Regulation
4
2018
456
0.080
Why?
Secondary Prevention
1
2010
85
0.080
Why?
HIV Seropositivity
1
2010
28
0.080
Why?
Immunity, Cellular
1
2010
64
0.080
Why?
Adjuvants, Immunologic
1
2010
52
0.080
Why?
Eukaryotic Initiation Factor-2
1
2010
18
0.080
Why?
Cell Line
2
2013
1016
0.080
Why?
Cells, Cultured
3
2013
1569
0.080
Why?
Ovarian Neoplasms
1
2014
459
0.080
Why?
Etoposide
2
2007
71
0.080
Why?
Placenta
1
2011
146
0.070
Why?
Transplantation, Heterologous
1
2009
78
0.070
Why?
Radiography
4
2012
476
0.070
Why?
Polymerase Chain Reaction
1
2010
452
0.070
Why?
Histones
2
2021
318
0.070
Why?
Cytotoxicity Tests, Immunologic
1
2008
26
0.070
Why?
Hospitalization
2
2024
749
0.070
Why?
Transcription Factors
2
2023
571
0.070
Why?
Liver Neoplasms
1
2012
347
0.070
Why?
Bone and Bones
3
2021
501
0.070
Why?
Lymphocyte Subsets
1
2008
14
0.070
Why?
Neoplastic Stem Cells
1
2009
90
0.070
Why?
Granulocyte Colony-Stimulating Factor
1
2008
64
0.070
Why?
Immunoglobulin lambda-Chains
1
2008
15
0.070
Why?
Haplotypes
1
2008
96
0.070
Why?
Cytogenetics
1
2008
23
0.070
Why?
Gene Deletion
1
2009
279
0.070
Why?
Ligands
1
2008
203
0.070
Why?
Osteogenesis
1
2011
374
0.070
Why?
Receptors, Immunologic
1
2008
36
0.070
Why?
Twins
1
2007
21
0.070
Why?
Busulfan
1
2007
18
0.070
Why?
Diphosphonates
1
2008
92
0.070
Why?
Herpesviridae Infections
2
2019
57
0.060
Why?
Immunophenotyping
1
2007
118
0.060
Why?
Leukocytes, Mononuclear
1
2007
122
0.060
Why?
Caspases
2
2018
101
0.060
Why?
Skin Neoplasms
1
2012
500
0.060
Why?
Antimetabolites
1
2006
12
0.060
Why?
Creatinine
1
2007
158
0.060
Why?
Blood Proteins
1
2007
84
0.060
Why?
Antibodies, Neoplasm
1
2006
27
0.060
Why?
Immunosuppressive Agents
1
2008
253
0.060
Why?
Graft vs Leukemia Effect
1
2006
2
0.060
Why?
Plasmacytoma
1
2006
45
0.060
Why?
Chromosome Banding
1
2006
24
0.060
Why?
Cohort Studies
3
2020
1557
0.060
Why?
MicroRNAs
1
2010
397
0.060
Why?
Imaging, Three-Dimensional
2
2017
145
0.060
Why?
Bone Marrow Transplantation
2
2022
110
0.060
Why?
Amiloride
1
2005
7
0.060
Why?
HLA-A2 Antigen
1
2005
11
0.060
Why?
Decision Trees
1
2025
23
0.060
Why?
Sensitivity and Specificity
1
2007
869
0.060
Why?
Tomography, X-Ray Computed
2
2023
1183
0.060
Why?
Child
3
2025
7384
0.060
Why?
Predictive Value of Tests
3
2018
933
0.060
Why?
Poly(ADP-ribose) Polymerases
2
2016
30
0.050
Why?
Japan
1
2025
42
0.050
Why?
Autoantigens
1
2025
46
0.050
Why?
Transmembrane Activator and CAML Interactor Protein
1
2024
6
0.050
Why?
Mendelian Randomization Analysis
1
2024
7
0.050
Why?
Phthalimides
1
2024
2
0.050
Why?
Piperidones
1
2024
6
0.050
Why?
Enoxaparin
1
2004
32
0.050
Why?
Telomere
1
2024
38
0.050
Why?
Retreatment
1
2024
60
0.050
Why?
NF-kappa B
2
2018
327
0.050
Why?
Morpholines
1
2024
64
0.050
Why?
Ferritins
1
2024
38
0.050
Why?
Cost of Illness
1
2024
121
0.050
Why?
Myeloid Progenitor Cells
1
2023
15
0.050
Why?
X-Ray Microtomography
1
2024
80
0.050
Why?
Neoplasms
1
2014
1335
0.050
Why?
Receptors, G-Protein-Coupled
1
2024
58
0.050
Why?
Epidemiologic Methods
3
2008
47
0.050
Why?
DNA, Neoplasm
2
2020
146
0.050
Why?
Fibroblasts
1
2005
363
0.050
Why?
Gene Silencing
2
2016
122
0.050
Why?
Cluster Analysis
3
2010
238
0.050
Why?
Cell Communication
1
2023
73
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Patients
1
2022
52
0.050
Why?
Geography
1
2022
65
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
32
0.040
Why?
Whole-Body Irradiation
1
2022
129
0.040
Why?
Guanine Nucleotide Exchange Factors
1
2022
18
0.040
Why?
Phenotype
1
2025
803
0.040
Why?
Inheritance Patterns
1
2022
22
0.040
Why?
Risk
2
2014
306
0.040
Why?
Primary Cell Culture
1
2022
62
0.040
Why?
Chromosomal Proteins, Non-Histone
1
2022
36
0.040
Why?
Quantitative Trait Loci
1
2022
53
0.040
Why?
Patient Selection
1
2023
273
0.040
Why?
Oncogenes
1
2021
61
0.040
Why?
Phylogeny
1
2022
231
0.040
Why?
Age of Onset
2
2013
109
0.040
Why?
Anticoagulants
1
2004
280
0.040
Why?
Child, Preschool
2
2020
4164
0.040
Why?
RANK Ligand
1
2022
188
0.040
Why?
Rabbits
2
2013
372
0.040
Why?
SOXC Transcription Factors
1
2021
13
0.040
Why?
Polymorphism, Genetic
1
2022
181
0.040
Why?
Transcriptional Activation
1
2021
128
0.040
Why?
Base Sequence
1
2022
620
0.040
Why?
Repressor Proteins
1
2022
149
0.040
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
69
0.040
Why?
Fibrosis
1
2021
198
0.040
Why?
Cyclin D2
1
2020
21
0.040
Why?
Spatio-Temporal Analysis
1
2020
11
0.040
Why?
Aneuploidy
1
2020
17
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
30
0.040
Why?
ras Proteins
1
2020
64
0.040
Why?
Histone Code
1
2020
32
0.040
Why?
Cyclin D1
1
2020
59
0.040
Why?
Chromosomes, Human, Pair 11
1
2020
56
0.040
Why?
Gene Expression Regulation, Leukemic
1
2020
32
0.040
Why?
Genome, Human
1
2021
121
0.040
Why?
Protein Kinase Inhibitors
1
2022
234
0.040
Why?
Single-Cell Analysis
1
2020
72
0.040
Why?
Mice, Transgenic
1
2021
561
0.040
Why?
Genetic Loci
1
2020
48
0.040
Why?
False Negative Reactions
1
2019
31
0.040
Why?
DNA Mutational Analysis
1
2020
179
0.040
Why?
Genetic Variation
1
2020
223
0.040
Why?
Neoplasm Invasiveness
1
2020
281
0.040
Why?
Incidence
2
2013
1085
0.040
Why?
Europe
1
2019
91
0.040
Why?
Herpesvirus 4, Human
1
2019
44
0.040
Why?
Communicable Disease Control
1
2019
37
0.040
Why?
Computational Biology
1
2020
209
0.040
Why?
Genome, Viral
1
2019
78
0.040
Why?
beta 2-Microglobulin
2
2009
39
0.040
Why?
RNA, Messenger
2
2016
1133
0.040
Why?
DNA, Viral
1
2019
136
0.040
Why?
Virus Diseases
1
2019
47
0.040
Why?
Fibrinogen
1
2018
33
0.040
Why?
Immunoglobulin A
1
2018
46
0.040
Why?
Glycogen Synthase Kinase 3
1
2018
21
0.030
Why?
DNA-Binding Proteins
1
2021
423
0.030
Why?
Bone Marrow Cells
2
2014
188
0.030
Why?
Platelet Count
2
2008
68
0.030
Why?
Promoter Regions, Genetic
1
2020
465
0.030
Why?
Receptor Protein-Tyrosine Kinases
1
2018
52
0.030
Why?
Pathology, Molecular
1
2018
28
0.030
Why?
Oncogene Proteins, Fusion
1
2018
62
0.030
Why?
Data Interpretation, Statistical
2
2010
169
0.030
Why?
Databases, Factual
2
2013
742
0.030
Why?
Kidney Function Tests
1
2017
55
0.030
Why?
False Positive Reactions
1
2017
66
0.030
Why?
Glomerular Filtration Rate
1
2017
128
0.030
Why?
Lamins
1
2016
5
0.030
Why?
Cell Transformation, Neoplastic
1
2018
187
0.030
Why?
Amino Acid Sequence
1
2018
563
0.030
Why?
Chromosomes, Human, Pair 16
1
2016
18
0.030
Why?
Internationality
1
2017
46
0.030
Why?
Alkaline Phosphatase
1
2017
92
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Genes, p53
1
2016
51
0.030
Why?
Lymphocytes, Tumor-Infiltrating
1
2017
89
0.030
Why?
Enzyme Activation
1
2016
267
0.030
Why?
Proteolysis
1
2016
105
0.030
Why?
Chromosome Mapping
2
2006
145
0.030
Why?
Glycolysis
1
2016
76
0.030
Why?
Prevalence
1
2019
1034
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
99
0.030
Why?
Phosphorylation
1
2016
533
0.030
Why?
Kidney Diseases
1
2017
230
0.030
Why?
Asymptomatic Diseases
1
2014
38
0.030
Why?
Gene Fusion
1
2014
9
0.030
Why?
Myocardium
1
2017
471
0.030
Why?
Interspersed Repetitive Sequences
1
2014
7
0.030
Why?
Capsid
1
2014
2
0.030
Why?
Lymphocyte Culture Test, Mixed
1
2014
6
0.030
Why?
HIV-1
1
2014
60
0.030
Why?
Homozygote
1
2013
57
0.020
Why?
Cerebrospinal Fluid
1
2013
29
0.020
Why?
Genetic Vectors
1
2014
127
0.020
Why?
Nicotinamide Mononucleotide
1
2013
4
0.020
Why?
Receptors, CXCR4
1
2013
30
0.020
Why?
Dependovirus
1
2014
104
0.020
Why?
Acrylamides
1
2013
12
0.020
Why?
Niacinamide
1
2013
24
0.020
Why?
Amides
1
2013
36
0.020
Why?
Enzyme Induction
1
2013
75
0.020
Why?
NAD
1
2013
45
0.020
Why?
Sirtuin 1
1
2013
29
0.020
Why?
Nitriles
1
2013
55
0.020
Why?
Chemokine CXCL12
1
2013
35
0.020
Why?
Gene Knockdown Techniques
1
2013
109
0.020
Why?
Transplantation Chimera
2
2003
16
0.020
Why?
RNA, Small Interfering
1
2013
214
0.020
Why?
Piperidines
1
2013
99
0.020
Why?
Infant
1
2020
3808
0.020
Why?
Induction Chemotherapy
1
2012
65
0.020
Why?
Lymphocyte Count
1
2011
20
0.020
Why?
Acute Disease
1
2013
393
0.020
Why?
Chemokine CXCL10
1
2011
20
0.020
Why?
HIV Infections
1
2016
402
0.020
Why?
Antibodies, Neutralizing
1
2011
78
0.020
Why?
Sex Factors
1
2013
747
0.020
Why?
Pharmacogenetics
1
2011
52
0.020
Why?
Enzyme Inhibitors
1
2013
371
0.020
Why?
Clinical Trials, Phase I as Topic
1
2010
24
0.020
Why?
Clinical Trials, Phase II as Topic
1
2010
48
0.020
Why?
Clinical Trials, Phase III as Topic
1
2010
48
0.020
Why?
Microarray Analysis
1
2010
69
0.020
Why?
International Classification of Diseases
1
2010
70
0.020
Why?
Argonaute Proteins
1
2010
12
0.020
Why?
RNA-Binding Proteins
1
2011
133
0.020
Why?
Oligonucleotides
1
2010
77
0.020
Why?
Polyploidy
1
2009
9
0.020
Why?
Bone Marrow Examination
1
2009
11
0.020
Why?
L-Lactate Dehydrogenase
1
2009
57
0.020
Why?
Neoplasm Metastasis
1
2009
237
0.020
Why?
Ploidies
1
2008
10
0.020
Why?
Chromosomes, Human, Pair 13
1
2008
37
0.020
Why?
Serum Albumin
1
2008
56
0.020
Why?
Polyethylene Glycols
1
2008
95
0.020
Why?
Xenograft Model Antitumor Assays
1
2008
228
0.020
Why?
Randomized Controlled Trials as Topic
1
2010
630
0.020
Why?
Age Distribution
1
2007
175
0.020
Why?
Recombinant Proteins
1
2008
489
0.020
Why?
Antineoplastic Agents, Hormonal
1
2007
56
0.020
Why?
Multigene Family
1
2006
50
0.020
Why?
Cyclin D
1
2006
18
0.020
Why?
Syndecans
1
2006
37
0.020
Why?
Cyclins
1
2006
38
0.020
Why?
RNA, Neoplasm
1
2006
45
0.010
Why?
Proteoglycans
1
2006
86
0.010
Why?
Leukemia, Myeloid, Acute
1
2007
208
0.010
Why?
Brain
1
2013
1353
0.010
Why?
Survivors
1
2006
120
0.010
Why?
Pregnancy
1
2011
2610
0.010
Why?
Probability
1
2003
171
0.010
Why?
Lymphocyte Transfusion
1
2003
10
0.010
Why?
Administration, Oral
1
2003
456
0.010
Why?
Tissue Donors
1
2003
130
0.010
Why?
Van Rhee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Same Department Expand Description